| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 9.88e-05 | 2 | 199 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 9.88e-05 | 2 | 199 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 9.88e-05 | 2 | 199 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 9.88e-05 | 2 | 199 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | IgM binding | 1.52e-04 | 11 | 199 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | calcium ion binding | MATN4 PKD1L2 TUBB4A FAT1 EFHC1 HMCN2 PCDHB1 HSPG2 PCDHGB3 PCDHA13 PCDHA10 PLCD4 CPS1 EYS MEGF8 PLA2G4B PLCH2 AOC3 DCHS1 | 1.86e-04 | 749 | 199 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KATNAL2 TUBB2B TUBB2A TUBB4A TUBB4B KIF3B PGP DNM1 DNAH9 ABCG5 DNM2 KIF2C CILP TUBB ABCB6 CHD1L ATP10A DHX30 HELZ2 DNM3 | 2.85e-04 | 839 | 199 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KATNAL2 TUBB2B TUBB2A TUBB4A TUBB4B KIF3B PGP DNM1 DNAH9 ABCG5 DNM2 KIF2C CILP TUBB ABCB6 CHD1L ATP10A DHX30 HELZ2 DNM3 | 2.89e-04 | 840 | 199 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KATNAL2 TUBB2B TUBB2A TUBB4A TUBB4B KIF3B PGP DNM1 DNAH9 ABCG5 DNM2 KIF2C CILP TUBB ABCB6 CHD1L ATP10A DHX30 HELZ2 DNM3 | 2.89e-04 | 840 | 199 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 3.51e-04 | 34 | 199 | 4 | GO:0008395 | |
| GeneOntologyMolecularFunction | 5'-3' RNA exonuclease activity | 5.85e-04 | 4 | 199 | 2 | GO:0004534 | |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 5.85e-04 | 4 | 199 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 5.85e-04 | 4 | 199 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 5.85e-04 | 4 | 199 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KATNAL2 TUBB2B TUBB2A TUBB4A TUBB4B KIF3B DNM1 DNAH9 ABCG5 DNM2 KIF2C TUBB ABCB6 CHD1L ATP10A DHX30 HELZ2 DNM3 | 7.79e-04 | 775 | 199 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 9.69e-04 | 5 | 199 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 9.69e-04 | 5 | 199 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 9.69e-04 | 5 | 199 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 9.81e-04 | 20 | 199 | 3 | GO:0016638 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.31e-03 | 22 | 199 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | type 5 metabotropic glutamate receptor binding | 1.44e-03 | 6 | 199 | 2 | GO:0031802 | |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 1.44e-03 | 6 | 199 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 1.69e-03 | 24 | 199 | 3 | GO:0120283 | |
| GeneOntologyBiologicalProcess | axonogenesis | ACHE NFASC TUBB2B NLGN3 NRXN3 HMCN2 PTPRS DNM2 PLXNA3 HSPG2 CNTNAP1 LAMA5 UST MAP1S MEGF8 KIAA1755 NUMB FYN | 8.82e-06 | 566 | 197 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 1.68e-05 | 6 | 197 | 3 | GO:0016098 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.57e-05 | 124 | 197 | 8 | GO:0001676 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ACHE ADGRB3 NFASC TUBB2B NLGN3 NRXN3 HMCN2 PTPRS DNM2 PLXNA3 HSPG2 CNTNAP1 LAMA5 UST MAP1S MEGF8 DNM3 KIAA1755 NUMB FYN | 3.41e-05 | 748 | 197 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | axon development | ACHE NFASC TUBB2B NLGN3 NRXN3 HMCN2 PTPRS DNM2 PLXNA3 HSPG2 CNTNAP1 LAMA5 UST MAP1S MEGF8 KIAA1755 NUMB FYN | 4.67e-05 | 642 | 197 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ACHE ADGRB3 NFASC TUBB2B NLGN3 FAT1 NRXN3 COCH HMCN2 PTPRS SCFD1 DNM2 PLXNA3 HSPG2 CNTNAP1 SH3KBP1 LAMA5 UST ATP10A MAP1S MEGF8 SH3D19 DNM3 KIAA1755 NUMB FYN | 7.36e-05 | 1194 | 197 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ACHE ADGRB3 NFASC TUBB2B NLGN3 NRXN3 HMCN2 PTPRS DNM2 PLXNA3 HSPG2 CNTNAP1 LAMA5 UST MAP1S MEGF8 DNM3 KIAA1755 NUMB FYN | 8.92e-05 | 802 | 197 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ACHE ADGRB3 NFASC TUBB2B NLGN3 NRXN3 HMCN2 PTPRS DNM2 PLXNA3 HSPG2 CNTNAP1 LAMA5 UST MAP1S MEGF8 DNM3 KIAA1755 NUMB FYN | 1.18e-04 | 819 | 197 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ACHE ADGRB3 NFASC TUBB2B NLGN3 NRXN3 HMCN2 PTPRS DNM2 PLXNA3 HSPG2 CNTNAP1 LAMA5 UST MAP1S MEGF8 DNM3 KIAA1755 NUMB FYN | 1.33e-04 | 826 | 197 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 1.34e-04 | 11 | 197 | 3 | GO:0016185 | |
| GeneOntologyCellularComponent | microtubule | KATNAL2 TUBB2B TUBB2A TUBB4A TUBB4B EFHC1 KIF3B DNM1 DNAH9 DNM2 KIF2C TUBB ARFGEF2 CLIP4 MAP1S DNM3 CDK1 | 1.57e-05 | 533 | 200 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | septate junction | 9.11e-05 | 2 | 200 | 2 | GO:0005918 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.42e-04 | 201 | 200 | 9 | GO:0072686 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.68e-04 | 33 | 200 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | tubulin complex | 2.72e-04 | 3 | 200 | 2 | GO:0045298 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ACHE HAPLN2 MATN4 SSPOP COCH HMCN2 HPX PZP HSPG2 CILP LAMA5 EYS CST4 MUC4 | 6.10e-04 | 530 | 200 | 14 | GO:0062023 |
| MousePheno | abnormal oligodendrocyte physiology | 2.64e-05 | 16 | 159 | 4 | MP:0008917 | |
| MousePheno | abnormal paranode morphology | 2.82e-05 | 6 | 159 | 3 | MP:0010734 | |
| Domain | Beta-tubulin_BS | 3.07e-08 | 10 | 198 | 5 | IPR013838 | |
| Domain | Beta_tubulin | 3.07e-08 | 10 | 198 | 5 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 5.59e-08 | 11 | 198 | 5 | PS00228 | |
| Domain | EGF_1 | MATN4 SSPOP FAT1 NRXN3 HMCN2 HSPG2 CNTNAP1 LAMA5 EYS TENM4 MEGF8 TENM1 ASTN1 MUC4 | 6.00e-07 | 255 | 198 | 14 | PS00022 |
| Domain | EGF_2 | MATN4 SSPOP FAT1 NRXN3 HMCN2 HSPG2 CNTNAP1 LAMA5 EYS TENM4 MEGF8 TENM1 ASTN1 MUC4 | 9.50e-07 | 265 | 198 | 14 | PS01186 |
| Domain | EGF_3 | MATN4 SSPOP FAT1 NRXN3 HMCN2 HSPG2 CNTNAP1 EYS TENM4 MEGF8 TENM1 ASTN1 MUC4 | 1.41e-06 | 235 | 198 | 13 | PS50026 |
| Domain | - | 1.73e-06 | 20 | 198 | 5 | 3.30.1330.20 | |
| Domain | - | 2.26e-06 | 21 | 198 | 5 | 1.10.287.600 | |
| Domain | EGF-like_dom | MATN4 FAT1 NRXN3 HMCN2 HSPG2 CNTNAP1 LAMA5 EYS TENM4 MEGF8 TENM1 ASTN1 MUC4 | 2.67e-06 | 249 | 198 | 13 | IPR000742 |
| Domain | LAM_G_DOMAIN | 2.74e-06 | 38 | 198 | 6 | PS50025 | |
| Domain | Tubulin_C | 2.90e-06 | 22 | 198 | 5 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 2.90e-06 | 22 | 198 | 5 | IPR018316 | |
| Domain | - | 2.90e-06 | 22 | 198 | 5 | 3.40.50.1440 | |
| Domain | Tubulin_C | 2.90e-06 | 22 | 198 | 5 | SM00865 | |
| Domain | Tub_FtsZ_C | 3.67e-06 | 23 | 198 | 5 | IPR008280 | |
| Domain | Tubulin_C | 3.67e-06 | 23 | 198 | 5 | IPR023123 | |
| Domain | TUBULIN | 3.67e-06 | 23 | 198 | 5 | PS00227 | |
| Domain | Tubulin | 3.67e-06 | 23 | 198 | 5 | IPR000217 | |
| Domain | Tubulin | 3.67e-06 | 23 | 198 | 5 | SM00864 | |
| Domain | Tubulin_CS | 3.67e-06 | 23 | 198 | 5 | IPR017975 | |
| Domain | Laminin_G_2 | 3.74e-06 | 40 | 198 | 6 | PF02210 | |
| Domain | EGF-like_CS | MATN4 FAT1 NRXN3 HMCN2 HSPG2 CNTNAP1 LAMA5 EYS TENM4 MEGF8 TENM1 ASTN1 MUC4 | 4.48e-06 | 261 | 198 | 13 | IPR013032 |
| Domain | Tubulin_FtsZ_GTPase | 4.59e-06 | 24 | 198 | 5 | IPR003008 | |
| Domain | Tubulin | 4.59e-06 | 24 | 198 | 5 | PF00091 | |
| Domain | LamG | 6.64e-06 | 44 | 198 | 6 | SM00282 | |
| Domain | EGF | MATN4 FAT1 NRXN3 HSPG2 CNTNAP1 LAMA5 EYS TENM4 MEGF8 TENM1 ASTN1 MUC4 | 8.18e-06 | 235 | 198 | 12 | SM00181 |
| Domain | Dynamin_central | 2.29e-05 | 6 | 198 | 3 | IPR000375 | |
| Domain | GED | 2.29e-05 | 6 | 198 | 3 | SM00302 | |
| Domain | Dynamin_M | 2.29e-05 | 6 | 198 | 3 | PF01031 | |
| Domain | GED_dom | 2.29e-05 | 6 | 198 | 3 | IPR020850 | |
| Domain | GED | 2.29e-05 | 6 | 198 | 3 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 2.29e-05 | 6 | 198 | 3 | IPR019762 | |
| Domain | GED | 2.29e-05 | 6 | 198 | 3 | PF02212 | |
| Domain | GED | 2.29e-05 | 6 | 198 | 3 | IPR003130 | |
| Domain | Laminin_G | 3.37e-05 | 58 | 198 | 6 | IPR001791 | |
| Domain | G_DYNAMIN_1 | 3.98e-05 | 7 | 198 | 3 | PS00410 | |
| Domain | DYNc | 3.98e-05 | 7 | 198 | 3 | SM00053 | |
| Domain | Put_53exo | 1.12e-04 | 2 | 198 | 2 | IPR004859 | |
| Domain | 5_3_exoribonuclease | 1.12e-04 | 2 | 198 | 2 | IPR027073 | |
| Domain | XRN_N | 1.12e-04 | 2 | 198 | 2 | PF03159 | |
| Domain | G_DYNAMIN_dom | 3.92e-04 | 14 | 198 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 3.92e-04 | 14 | 198 | 3 | PS51718 | |
| Domain | EGF | 3.95e-04 | 126 | 198 | 7 | PF00008 | |
| Domain | Dynamin_GTPase | 4.86e-04 | 15 | 198 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 4.86e-04 | 15 | 198 | 3 | IPR022812 | |
| Domain | Dynamin_N | 4.86e-04 | 15 | 198 | 3 | PF00350 | |
| Domain | - | 5.23e-04 | 95 | 198 | 6 | 2.60.120.200 | |
| Domain | ConA-like_dom | 5.63e-04 | 219 | 198 | 9 | IPR013320 | |
| Domain | IG | HAPLN2 NFASC PTGFRN IGSF22 HMCN2 PTPRS HSPG2 LILRA1 CILP TMIGD2 IGSF1 FCAMR LILRA4 | 5.76e-04 | 421 | 198 | 13 | SM00409 |
| Domain | Ig_sub | HAPLN2 NFASC PTGFRN IGSF22 HMCN2 PTPRS HSPG2 LILRA1 CILP TMIGD2 IGSF1 FCAMR LILRA4 | 5.76e-04 | 421 | 198 | 13 | IPR003599 |
| Domain | Tox-GHH_dom | 6.62e-04 | 4 | 198 | 2 | IPR028916 | |
| Domain | Pecanex_C | 6.62e-04 | 4 | 198 | 2 | PF05041 | |
| Domain | Tox-GHH | 6.62e-04 | 4 | 198 | 2 | PF15636 | |
| Domain | Ten_N | 6.62e-04 | 4 | 198 | 2 | IPR009471 | |
| Domain | Ten_N | 6.62e-04 | 4 | 198 | 2 | PF06484 | |
| Domain | TENEURIN_N | 6.62e-04 | 4 | 198 | 2 | PS51361 | |
| Domain | Pecanex | 6.62e-04 | 4 | 198 | 2 | IPR007735 | |
| Domain | ASX_HYDROXYL | 6.87e-04 | 100 | 198 | 6 | PS00010 | |
| Domain | IGc2 | 9.31e-04 | 235 | 198 | 9 | SM00408 | |
| Domain | Ig_sub2 | 9.31e-04 | 235 | 198 | 9 | IPR003598 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.32e-04 | 106 | 198 | 6 | IPR000152 | |
| Domain | ig | 9.72e-04 | 190 | 198 | 8 | PF00047 | |
| Domain | Immunoglobulin | 9.72e-04 | 190 | 198 | 8 | IPR013151 | |
| Domain | Cadherin_CS | 1.08e-03 | 109 | 198 | 6 | IPR020894 | |
| Domain | Gal_Lectin | 1.09e-03 | 5 | 198 | 2 | PF02140 | |
| Domain | YD | 1.09e-03 | 5 | 198 | 2 | IPR006530 | |
| Domain | Lectin_gal-bd_dom | 1.09e-03 | 5 | 198 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.09e-03 | 5 | 198 | 2 | PS50228 | |
| Domain | CADHERIN_1 | 1.30e-03 | 113 | 198 | 6 | PS00232 | |
| Domain | Cadherin | 1.30e-03 | 113 | 198 | 6 | PF00028 | |
| Domain | Cyt_P450_E_grp-I | 1.30e-03 | 45 | 198 | 4 | IPR002401 | |
| Domain | CADHERIN_2 | 1.36e-03 | 114 | 198 | 6 | PS50268 | |
| Domain | - | 1.36e-03 | 114 | 198 | 6 | 2.60.40.60 | |
| Domain | Growth_fac_rcpt_ | 1.39e-03 | 156 | 198 | 7 | IPR009030 | |
| Domain | CA | 1.42e-03 | 115 | 198 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.49e-03 | 116 | 198 | 6 | IPR015919 | |
| Domain | Cadherin | 1.62e-03 | 118 | 198 | 6 | IPR002126 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.63e-03 | 6 | 198 | 2 | IPR016332 | |
| Domain | EGF_CA | 1.92e-03 | 122 | 198 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.09e-03 | 124 | 198 | 6 | IPR001881 | |
| Domain | IG_LIKE | HAPLN2 NFASC PTGFRN IGSF22 HMCN2 PTPRS HSPG2 LILRA1 CILP TMIGD2 IGSF1 FCAMR LILRA4 | 2.30e-03 | 491 | 198 | 13 | PS50835 |
| Domain | Cyt_P450_CS | 2.39e-03 | 53 | 198 | 4 | IPR017972 | |
| Domain | Ig-like_dom | HAPLN2 NFASC PTGFRN IGSF22 HMCN2 PTPRS HSPG2 LILRA1 CILP TMIGD2 IGSF1 FCAMR LILRA4 | 2.83e-03 | 503 | 198 | 13 | IPR007110 |
| Domain | LAMININ_IVA | 3.00e-03 | 8 | 198 | 2 | PS51115 | |
| Domain | Laminin_B | 3.00e-03 | 8 | 198 | 2 | PF00052 | |
| Domain | LamB | 3.00e-03 | 8 | 198 | 2 | SM00281 | |
| Domain | Laminin_IV | 3.00e-03 | 8 | 198 | 2 | IPR000034 | |
| Domain | CYTOCHROME_P450 | 3.12e-03 | 57 | 198 | 4 | PS00086 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.48e-09 | 37 | 141 | 8 | MM15102 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.32e-08 | 68 | 141 | 9 | MM14968 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.62e-08 | 49 | 141 | 8 | M891 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 7.90e-08 | 23 | 141 | 6 | M47910 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.41e-07 | 116 | 141 | 10 | MM14855 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | NFASC TUBB2B TUBB2A TUBB4A TUBB4B DNM1 DNM2 CNTNAP1 DNM3 NUMB | 3.58e-07 | 121 | 141 | 10 | M872 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 5.22e-07 | 126 | 141 | 10 | M705 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 5.24e-07 | 17 | 141 | 5 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.19e-07 | 18 | 141 | 5 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.69e-07 | 19 | 141 | 5 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.69e-07 | 19 | 141 | 5 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.28e-06 | 20 | 141 | 5 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.28e-06 | 20 | 141 | 5 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.67e-06 | 21 | 141 | 5 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 2.14e-06 | 22 | 141 | 5 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.71e-06 | 23 | 141 | 5 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 3.40e-06 | 24 | 141 | 5 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.40e-06 | 24 | 141 | 5 | M47700 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.05e-06 | 43 | 141 | 6 | M47669 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 4.22e-06 | 25 | 141 | 5 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.22e-06 | 25 | 141 | 5 | M47710 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.65e-06 | 44 | 141 | 6 | MM14606 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.18e-06 | 26 | 141 | 5 | M47672 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.32e-06 | 45 | 141 | 6 | M47670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 7.61e-06 | 28 | 141 | 5 | M47898 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.12e-05 | 51 | 141 | 6 | M26972 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | NFASC TUBB2B TUBB2A TUBB4A TUBB4B DNM1 DNM2 PLXNA3 SH3KBP1 DNM3 NUMB FYN | 1.21e-05 | 261 | 141 | 12 | MM15676 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.74e-05 | 55 | 141 | 6 | M39613 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.77e-05 | 33 | 141 | 5 | M47901 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.94e-05 | 56 | 141 | 6 | M2333 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.06e-05 | 17 | 141 | 4 | MM14731 | |
| Pathway | REACTOME_KINESINS | 2.15e-05 | 57 | 141 | 6 | MM15714 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.38e-05 | 35 | 141 | 5 | M47774 | |
| Pathway | WP_MELATONIN_METABOLISM_AND_EFFECTS | 3.14e-05 | 37 | 141 | 5 | M39418 | |
| Pathway | REACTOME_KINESINS | 3.18e-05 | 61 | 141 | 6 | M977 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 5.03e-05 | 21 | 141 | 4 | M27067 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 5.92e-05 | 68 | 141 | 6 | MM14921 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 6.61e-05 | 43 | 141 | 5 | M47773 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 7.33e-05 | 23 | 141 | 4 | M19135 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.21e-04 | 26 | 141 | 4 | M9648 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.41e-04 | 27 | 141 | 4 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.41e-04 | 27 | 141 | 4 | MM15674 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.52e-04 | 11 | 141 | 3 | M27130 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.66e-04 | 52 | 141 | 5 | MM15211 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.88e-04 | 29 | 141 | 4 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.88e-04 | 29 | 141 | 4 | M27948 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.99e-04 | 54 | 141 | 5 | M27482 | |
| Pathway | KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM | 2.45e-04 | 31 | 141 | 4 | M766 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.77e-04 | 32 | 141 | 4 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.77e-04 | 32 | 141 | 4 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.77e-04 | 32 | 141 | 4 | MM14730 | |
| Pathway | KEGG_GAP_JUNCTION | 2.81e-04 | 90 | 141 | 6 | M4013 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.81e-04 | 90 | 141 | 6 | MM14979 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 3.13e-04 | 33 | 141 | 4 | M27297 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 3.29e-04 | 14 | 141 | 3 | M10122 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.56e-04 | 94 | 141 | 6 | MM14515 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.77e-04 | 95 | 141 | 6 | M6729 | |
| Pathway | REACTOME_AGGREPHAGY | 4.41e-04 | 36 | 141 | 4 | MM15669 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.45e-04 | 98 | 141 | 6 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 4.45e-04 | 98 | 141 | 6 | M776 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.70e-04 | 138 | 141 | 7 | MM15635 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.96e-04 | 100 | 141 | 6 | M27650 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 5.11e-04 | 66 | 141 | 5 | MM17074 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.44e-04 | 38 | 141 | 4 | M14981 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 6.12e-04 | 104 | 141 | 6 | M738 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 6.25e-04 | 189 | 141 | 8 | MM15356 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 6.43e-04 | 105 | 141 | 6 | MM14842 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 7.15e-04 | 71 | 141 | 5 | M39690 | |
| Pathway | KEGG_PHENYLALANINE_METABOLISM | 7.16e-04 | 18 | 141 | 3 | M16650 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | TUBB2B TUBB2A TUBB4A TUBB4B KIF3B HPX SCFD1 DNM1 VPS37D DNM2 ALPP KIF2C SH3KBP1 COG8 SH3D19 DNM3 | 7.21e-04 | 645 | 141 | 16 | MM15232 |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 7.62e-04 | 72 | 141 | 5 | M26954 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 7.62e-04 | 72 | 141 | 5 | M9257 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 8.04e-04 | 151 | 141 | 7 | M550 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 8.12e-04 | 73 | 141 | 5 | MM15491 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 9.33e-04 | 201 | 141 | 8 | M27472 | |
| Pathway | REACTOME_AGGREPHAGY | 9.54e-04 | 44 | 141 | 4 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 9.54e-04 | 44 | 141 | 4 | M27934 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 9.74e-04 | 5 | 141 | 2 | M27759 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 9.74e-04 | 5 | 141 | 2 | MM15504 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 9.75e-04 | 76 | 141 | 5 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 9.75e-04 | 76 | 141 | 5 | M27215 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 9.95e-04 | 203 | 141 | 8 | M27654 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.08e-03 | 116 | 141 | 6 | MM15715 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.13e-03 | 46 | 141 | 4 | M27828 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.14e-03 | 21 | 141 | 3 | M39631 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | CYP2C19 CYP2C9 CYP2D6 MAOA NLGN3 NRXN3 KCNA6 SLC52A2 CNTNAP1 GRIA4 BECN1 | 1.15e-03 | 367 | 141 | 11 | M48346 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.16e-03 | 79 | 141 | 5 | M27743 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.33e-03 | 48 | 141 | 4 | MM15353 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 1.45e-03 | 6 | 141 | 2 | M27909 | |
| Pathway | REACTOME_XENOBIOTICS | 1.50e-03 | 23 | 141 | 3 | M5372 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.52e-03 | 217 | 141 | 8 | MM14708 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | TUBB2B TUBB2A TUBB4A TUBB4B KIF3B SCFD1 DNM1 VPS37D DNM2 ALPP KIF2C SH3KBP1 COG8 SH3D19 DNM3 | 1.60e-03 | 630 | 141 | 15 | M11480 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.73e-03 | 127 | 141 | 6 | M27181 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.79e-03 | 52 | 141 | 4 | MM14949 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.87e-03 | 129 | 141 | 6 | MM14894 | |
| Pathway | REACTOME_XENOBIOTICS | 1.92e-03 | 25 | 141 | 3 | MM14846 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.92e-03 | 53 | 141 | 4 | M27651 | |
| Pathway | REACTOME_NEUROFASCIN_INTERACTIONS | 2.02e-03 | 7 | 141 | 2 | M27380 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.02e-03 | 131 | 141 | 6 | MM15497 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.27e-03 | 134 | 141 | 6 | M27751 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 3.65e-10 | 8 | 204 | 5 | 23246003 | |
| Pubmed | ACOT9 GART TUBB2B PTGFRN DPM1 TUBB4A COCH PTPRS RPF2 MTCH2 DNM2 ALPP HSPG2 CNTNAP1 TUBB LAMA5 CPS1 TXNDC15 MEGF8 CDK1 | 7.42e-10 | 613 | 204 | 20 | 22268729 | |
| Pubmed | 1.15e-09 | 4 | 204 | 4 | 11120798 | ||
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 5.72e-09 | 5 | 204 | 4 | 21296049 | |
| Pubmed | 1.71e-08 | 6 | 204 | 4 | 3782288 | ||
| Pubmed | 1.71e-08 | 6 | 204 | 4 | 24275654 | ||
| Pubmed | 1.25e-07 | 21 | 204 | 5 | 30110642 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 1.61e-07 | 22 | 204 | 5 | 16526095 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.61e-07 | 22 | 204 | 5 | 23826228 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 1.61e-07 | 22 | 204 | 5 | 30446499 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXK2 PCNX3 HIRA PCNX2 FAT1 PTPRS UCKL1 SLC52A2 PLXNA3 HSPG2 ARFGEF2 LAMA5 DHX30 TLNRD1 INTS5 ARAP3 MAP1S SLC16A5 MEGF8 SND1 PLA2G4B HELZ2 UBE3C | 1.68e-07 | 1105 | 204 | 23 | 35748872 |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 16236141 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 24798722 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 12511974 | ||
| Pubmed | Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. | 1.99e-07 | 3 | 204 | 3 | 15177309 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 15813658 | ||
| Pubmed | CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. | 1.99e-07 | 3 | 204 | 3 | 18240905 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 24338437 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 6688039 | ||
| Pubmed | Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technology. | 1.99e-07 | 3 | 204 | 3 | 15090156 | |
| Pubmed | Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus? | 1.99e-07 | 3 | 204 | 3 | 19192051 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 12383797 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 21108610 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 24273169 | ||
| Pubmed | Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects. | 1.99e-07 | 3 | 204 | 3 | 29181698 | |
| Pubmed | Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. | 1.99e-07 | 3 | 204 | 3 | 19151603 | |
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 1.99e-07 | 3 | 204 | 3 | 28395327 | |
| Pubmed | Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series. | 1.99e-07 | 3 | 204 | 3 | 25803758 | |
| Pubmed | Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. | 1.99e-07 | 3 | 204 | 3 | 12950145 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 32469422 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 21861665 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 12360109 | ||
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 12517701 | ||
| Pubmed | Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics. | 1.99e-07 | 3 | 204 | 3 | 14520122 | |
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 1.99e-07 | 3 | 204 | 3 | 24046449 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | KATNAL2 GART TUBB2B DPM1 TUBB2A PDCD4 TUBB4A TUBB4B UTP15 PPIL2 BCAR3 KIF2C MPG XRN2 TUBB CPS1 RBM39 DHX30 SND1 NUMB FYN | 2.22e-07 | 949 | 204 | 21 | 36574265 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | PKD1L2 CYP46A1 FAT1 COCH HMCN2 DNAH9 CALCOCO1 CHD1L VWA7 ATP10A RBM39 PCF11 MAP1S | 2.54e-07 | 361 | 204 | 13 | 26167880 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GART TUBB2B DPM1 HIRA TUBB4B UTP15 RPF2 XRN1 SCFD1 PGP MGA KIF2C MPG XRN2 GNE TUBB ELP1 SAE1 CHD1L RBM39 DHX30 AAAS ARAP3 SND1 CDK1 | 4.38e-07 | 1353 | 204 | 25 | 29467282 |
| Pubmed | ADGRB3 TUBB2B DPM1 TUBB2A TUBB4A TUBB4B DNM1 QKI DNM2 XRN2 CNTNAP1 TUBB ARFGEF2 INTS8 DHX30 CLIP4 HEATR6 TXNDC15 MAP1S SH3D19 DNM3 ASTN1 PALS2 BECN1 | 6.27e-07 | 1285 | 204 | 24 | 35914814 | |
| Pubmed | TRAIP NFASC PDIA2 DNM1 ABCG5 DNM2 CNTNAP1 SH3KBP1 PCDHA10 DNM3 TSKS FYN | 6.49e-07 | 329 | 204 | 12 | 17474147 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | TUBB2B TUBB2A TUBB4A TUBB4B DNM2 HSPG2 TUBB LAMA5 RBM39 PBRM1 | 7.58e-07 | 219 | 204 | 10 | 31353912 |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 7.73e-07 | 54 | 204 | 6 | 21525035 | |
| Pubmed | Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori. | 7.92e-07 | 4 | 204 | 3 | 18425152 | |
| Pubmed | Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy. | 7.92e-07 | 4 | 204 | 3 | 24340040 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 16924387 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 17635181 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 19164093 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 7.92e-07 | 4 | 204 | 3 | 21689597 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 22846998 | ||
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 7.92e-07 | 4 | 204 | 3 | 16025294 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 19593158 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 19545277 | ||
| Pubmed | ADGRB3 NFASC TUBB2B HIRA NLGN3 KIF3B PTPRS DNM1 MGA DNM2 KIF2C CALCOCO1 CNTNAP1 SH3KBP1 GRIA4 PEX5L PBRM1 SH3D19 DCHS1 DNM3 | 1.17e-06 | 963 | 204 | 20 | 28671696 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 17418993 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 15691505 | ||
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 1.97e-06 | 5 | 204 | 3 | 20857895 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 12900870 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 9722593 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 18024866 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 21071160 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 1.97e-06 | 5 | 204 | 3 | 3839797 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 25552922 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 19823875 | ||
| Pubmed | 2.58e-06 | 17 | 204 | 4 | 17360745 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 23640057 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 27251629 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 16401082 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 18602423 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 16595916 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 18231117 | ||
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 12879168 | ||
| Pubmed | HAPLN2 NFASC TUBB2B TUBB2A NLGN3 TUBB4A TUBB4B PTPRS SLC27A1 XRN1 DNM1 MTCH2 DNM2 CALCOCO1 CNTNAP1 SH3KBP1 TUBB ARFGEF2 ELP1 RBM39 DHX30 TENM4 MAP1S SND1 | 4.03e-06 | 1431 | 204 | 24 | 37142655 | |
| Pubmed | 4.16e-06 | 19 | 204 | 4 | 15698476 | ||
| Pubmed | 4.16e-06 | 19 | 204 | 4 | 15691386 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TUBB2B DPM1 TUBB4A TUBB4B UTP15 SCFD1 XRN2 TUBB ELP1 SAE1 CPS1 DHX30 AAAS MAP1S SND1 CDK1 | 4.68e-06 | 704 | 204 | 16 | 29955894 |
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 4.71e-06 | 42 | 204 | 5 | 14760703 | |
| Pubmed | TUBB2B CYP46A1 TUBB2A TUBB4A TUBB4B KCNA6 CNTNAP1 TUBB TENM4 PLCH2 NUMB FYN | 5.55e-06 | 405 | 204 | 12 | 38187761 | |
| Pubmed | Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. | 6.84e-06 | 7 | 204 | 3 | 19891553 | |
| Pubmed | Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. | 6.84e-06 | 7 | 204 | 3 | 9553134 | |
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 27010057 | ||
| Pubmed | Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. | 6.84e-06 | 7 | 204 | 3 | 19219744 | |
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 15252009 | ||
| Pubmed | FOXK2 DPM1 PDCD4 RPF2 PPIL2 DNM2 XRN2 GNE ELP1 RBM39 DHX30 SND1 CDK1 UBE3C PALS2 | 8.24e-06 | 653 | 204 | 15 | 33742100 | |
| Pubmed | CCDC134 GART TUBB4B FAT1 TM9SF2 FBXO3 MTCH2 DNM2 ALPP CALCOCO1 CNTNAP1 TUBB LAMA5 QTRT2 DHX30 TXNDC15 MAP1S SND1 NUMB CDK1 UBE3C FYN | 8.77e-06 | 1297 | 204 | 22 | 33545068 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | ACOT9 GART DPM1 TUBB2A TUBB4A TUBB4B ALPP XRN2 TUBB CPS1 RBM39 DHX30 CDK1 FYN | 9.57e-06 | 580 | 204 | 14 | 35676659 |
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 20430047 | ||
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 18356043 | ||
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 20147896 | ||
| Pubmed | ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | 1.09e-05 | 8 | 204 | 3 | 19593168 | |
| Pubmed | 1.09e-05 | 8 | 204 | 3 | 24282027 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACOT9 GART TUBB2B DPM1 PDCD4 TUBB4B UTP15 RPF2 CRYBG1 SCFD1 DNM2 KIF2C XRN2 TUBB SAE1 CHD1L RBM39 DHX30 PBRM1 CCDC71 SND1 CDK1 | 1.13e-05 | 1318 | 204 | 22 | 30463901 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.13e-05 | 235 | 204 | 9 | 28378594 | |
| Pubmed | [Analysis of genetic predisposition to pulmonary tuberculosis in native Russians]. | 1.63e-05 | 9 | 204 | 3 | 20297661 | |
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 17178267 | ||
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 19350405 | ||
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 23170932 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | TIMM17B GART TUBB2B DPM1 TUBB2A TUBB4A TUBB4B DNM2 XRN2 TUBB ELP1 SAE1 QTRT2 CHD1L RBM39 DHX30 AAAS MAP1S SND1 CDK1 UBE3C | 1.78e-05 | 1257 | 204 | 21 | 37317656 |
| Pubmed | 1.81e-05 | 27 | 204 | 4 | 20173083 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 18061941 | ||
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 2.31e-05 | 10 | 204 | 3 | 23986237 | |
| Interaction | TPSB2 interactions | 1.40e-08 | 18 | 198 | 6 | int:TPSB2 | |
| Interaction | GLMP interactions | 1.39e-07 | 84 | 198 | 9 | int:GLMP | |
| Interaction | CAPS interactions | 3.94e-06 | 25 | 198 | 5 | int:CAPS | |
| Interaction | ZC2HC1B interactions | 7.12e-06 | 28 | 198 | 5 | int:ZC2HC1B | |
| Interaction | GZMH interactions | 8.20e-06 | 74 | 198 | 7 | int:GZMH | |
| Interaction | FBXO6 interactions | ACOT9 GART TUBB2B PTGFRN DPM1 TUBB4A COCH PTPRS RPF2 MTCH2 DNM2 ALPP HSPG2 CNTNAP1 TUBB LAMA5 CPS1 TXNDC15 TENM4 MEGF8 CDK1 | 8.40e-06 | 717 | 198 | 21 | int:FBXO6 |
| Interaction | ASCL4 interactions | 2.48e-05 | 18 | 198 | 4 | int:ASCL4 | |
| Interaction | NLGN3 interactions | 5.52e-05 | 99 | 198 | 7 | int:NLGN3 | |
| Interaction | LY86 interactions | RTKN PTGFRN TUBB2A TUBB4A BMP8A PLXNA3 CNTNAP1 TUBB LAMA5 RBPMS2 | 5.94e-05 | 217 | 198 | 10 | int:LY86 |
| Interaction | BAGE2 interactions | 6.48e-05 | 70 | 198 | 6 | int:BAGE2 | |
| Interaction | NFYC interactions | 6.57e-05 | 177 | 198 | 9 | int:NFYC | |
| GeneFamily | Tubulins | 1.30e-06 | 26 | 136 | 5 | 778 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 8.26e-04 | 6 | 136 | 2 | 1181 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN | PFKFB4 PDCD4 TGM5 XRN2 TUBB CLIP4 EVA1C CCDC71 MEGF8 AVIL TSKS STAG3 | 5.16e-08 | 200 | 201 | 12 | M3571 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 202 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 202 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 202 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 9.88e-07 | 167 | 202 | 8 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.03e-06 | 168 | 202 | 8 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 1.47e-06 | 176 | 202 | 8 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.04e-06 | 184 | 202 | 8 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-06 | 200 | 202 | 8 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-06 | 150 | 202 | 7 | 98fdc6bdfde84d680e11d8727502b79afbf64303 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 160 | 202 | 7 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 160 | 202 | 7 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 160 | 202 | 7 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 160 | 202 | 7 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.38e-06 | 162 | 202 | 7 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 164 | 202 | 7 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 1.10e-05 | 166 | 202 | 7 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 174 | 202 | 7 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 174 | 202 | 7 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 174 | 202 | 7 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-05 | 116 | 202 | 6 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-05 | 176 | 202 | 7 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-05 | 177 | 202 | 7 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 179 | 202 | 7 | e520eadde4f1b7fb868dbbe94c4d62b3776c55eb | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 180 | 202 | 7 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 180 | 202 | 7 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 181 | 202 | 7 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 181 | 202 | 7 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 181 | 202 | 7 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 183 | 202 | 7 | 0f6799e4f058bed546fe5759502430f4a19635da | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 183 | 202 | 7 | 8ef5223e46f1fd81a856261248cc77e7c7e72ef6 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 188 | 202 | 7 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 188 | 202 | 7 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.54e-05 | 189 | 202 | 7 | 659deb617a560bcde67c75f477d30ce85aaec3c6 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.54e-05 | 189 | 202 | 7 | 67f9a9861d2dcc128b7a69432c6b31da185e2249 | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 2.72e-05 | 191 | 202 | 7 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 192 | 202 | 7 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 2.90e-05 | 193 | 202 | 7 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.00e-05 | 194 | 202 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 196 | 202 | 7 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 196 | 202 | 7 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 197 | 202 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 197 | 202 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 197 | 202 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.42e-05 | 198 | 202 | 7 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 3.42e-05 | 198 | 202 | 7 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | Control-Control-Others-RBC|Control / Disease, condition lineage and cell class | 3.53e-05 | 199 | 202 | 7 | eb4c52d04f572433c0239bf479d0040a309939a1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.64e-05 | 200 | 202 | 7 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.64e-05 | 200 | 202 | 7 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.64e-05 | 200 | 202 | 7 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | CTRL-Lymphoid-pDC|CTRL / Disease state, Lineage and Cell class | 4.16e-05 | 139 | 202 | 6 | bbc10812b0c5b8c85e78171c12316becde8895c3 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-05 | 144 | 202 | 6 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.90e-05 | 148 | 202 | 6 | 1d9fa6b2ee9feaed39c63d44e638b5c0942d947c | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 156 | 202 | 6 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.77e-05 | 159 | 202 | 6 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 9.08e-05 | 160 | 202 | 6 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-05 | 160 | 202 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 9.40e-05 | 161 | 202 | 6 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-05 | 161 | 202 | 6 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-05 | 161 | 202 | 6 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-04 | 163 | 202 | 6 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 163 | 202 | 6 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 164 | 202 | 6 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 165 | 202 | 6 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 1.11e-04 | 166 | 202 | 6 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 168 | 202 | 6 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 168 | 202 | 6 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 169 | 202 | 6 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 169 | 202 | 6 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-04 | 169 | 202 | 6 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 1.27e-04 | 170 | 202 | 6 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.27e-04 | 170 | 202 | 6 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 171 | 202 | 6 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 171 | 202 | 6 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 173 | 202 | 6 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 173 | 202 | 6 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 173 | 202 | 6 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.44e-04 | 174 | 202 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-04 | 175 | 202 | 6 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-04 | 175 | 202 | 6 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 1.48e-04 | 175 | 202 | 6 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-04 | 175 | 202 | 6 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-04 | 175 | 202 | 6 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.53e-04 | 176 | 202 | 6 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 176 | 202 | 6 | ce950805aaa3d39630376028ecd7da584fdb4394 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 176 | 202 | 6 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 1.53e-04 | 176 | 202 | 6 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 176 | 202 | 6 | 5b65693833e02c08530488cbe37883e7c75f312e | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 177 | 202 | 6 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | Healthy-RBC|Healthy / disease group, cell group and cell class | 1.58e-04 | 177 | 202 | 6 | 945d72ab52efa9a9468daace9f9ec676a891d963 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 1.63e-04 | 178 | 202 | 6 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 179 | 202 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.68e-04 | 179 | 202 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 180 | 202 | 6 | adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.83e-04 | 182 | 202 | 6 | 02e04294fce12591c32d7bd0e866a000ad1f836e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 182 | 202 | 6 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-04 | 184 | 202 | 6 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 184 | 202 | 6 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| Computational | Intracellular transport (MT cytoskeleton and motors). | 9.52e-05 | 21 | 127 | 4 | MODULE_253 | |
| Computational | Genes in the cancer module 196. | 1.38e-04 | 23 | 127 | 4 | MODULE_196 | |
| Drug | 2-demethylcolchicine | 1.02e-08 | 32 | 200 | 7 | CID000023757 | |
| Drug | colchiceine | 3.64e-08 | 38 | 200 | 7 | CID000010156 | |
| Drug | Stylophorin | 8.96e-08 | 43 | 200 | 7 | CID000010147 | |
| Drug | imipramine | CYP2C19 CYP2C9 CYP2D6 MAOA ACHE TUBB2B RTKN TUBB2A TUBB4A TUBB4B TUBB PLCD4 AOC3 | 1.74e-07 | 235 | 200 | 13 | CID000003696 |
| Drug | 5-fluoro-alpha-methyltryptamine | 3.93e-07 | 8 | 200 | 4 | ctd:C051101 | |
| Drug | 5-methyltryptamine | 3.93e-07 | 8 | 200 | 4 | ctd:C027552 | |
| Drug | 5-bromotryptamine | 3.93e-07 | 8 | 200 | 4 | ctd:C040997 | |
| Drug | 7-methyltryptamine | 3.93e-07 | 8 | 200 | 4 | ctd:C036696 | |
| Drug | 2-phenyl-4-quinolone | 4.67e-07 | 34 | 200 | 6 | CID000161091 | |
| Drug | 5-chlorotryptamine | 7.03e-07 | 9 | 200 | 4 | ctd:C529169 | |
| Drug | erianin | 1.09e-06 | 39 | 200 | 6 | CID000356759 | |
| Drug | 2,3,4-tabp | 1.47e-06 | 23 | 200 | 5 | CID000125548 | |
| Drug | NSC355636 | 1.47e-06 | 23 | 200 | 5 | CID000100176 | |
| Drug | IKP104 | 1.47e-06 | 23 | 200 | 5 | CID000130739 | |
| Drug | 2,3,4-TCB | 1.47e-06 | 23 | 200 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 1.47e-06 | 23 | 200 | 5 | CID000097865 | |
| Drug | PIPES | 1.48e-06 | 64 | 200 | 7 | CID000079723 | |
| Drug | nitrendipine; Up 200; 10uM; MCF7; HG-U133A | ALLC PHF20 HPX PCDHB1 AAAS ARAP3 FAM13A SND1 DCHS1 FUT2 STAG3 | 1.51e-06 | 198 | 200 | 11 | 336_UP |
| Drug | parbendazole | 1.85e-06 | 24 | 200 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 1.85e-06 | 24 | 200 | 5 | CID000016546 | |
| Drug | NABV | 1.85e-06 | 24 | 200 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 1.85e-06 | 24 | 200 | 5 | CID000163705 | |
| Drug | NSC-36768 | 1.85e-06 | 24 | 200 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.85e-06 | 24 | 200 | 5 | CID000014995 | |
| Drug | colchicide | 1.85e-06 | 24 | 200 | 5 | CID000120712 | |
| Drug | benomyl | 2.01e-06 | 128 | 200 | 9 | CID000028780 | |
| Drug | AC1Q6P06 | 2.29e-06 | 25 | 200 | 5 | CID000160263 | |
| Drug | allocolchicine | 2.29e-06 | 25 | 200 | 5 | CID000196989 | |
| Drug | 55623-37-5 | 2.29e-06 | 25 | 200 | 5 | CID006438440 | |
| Drug | MDL 27048 | 2.29e-06 | 25 | 200 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 2.29e-06 | 25 | 200 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.29e-06 | 25 | 200 | 5 | CID000043264 | |
| Drug | NSC142227 | 2.29e-06 | 25 | 200 | 5 | CID000073427 | |
| Drug | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | 2.65e-06 | 4 | 200 | 3 | ctd:C558737 | |
| Drug | rabeprazole-thioether | 2.65e-06 | 4 | 200 | 3 | ctd:C523099 | |
| Drug | 2-Tbmbfd | 2.71e-06 | 12 | 200 | 4 | CID000126928 | |
| Drug | NSC527981 | 2.82e-06 | 26 | 200 | 5 | CID000352796 | |
| Drug | NSC332029 | 2.82e-06 | 26 | 200 | 5 | CID000100073 | |
| Drug | pironetin | 2.82e-06 | 26 | 200 | 5 | CID006438891 | |
| Drug | AC1L1J4H | 3.43e-06 | 27 | 200 | 5 | CID000004862 | |
| Drug | dinitroanilines | 3.43e-06 | 27 | 200 | 5 | CID000136400 | |
| Drug | NSC292222 | 3.43e-06 | 27 | 200 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 3.43e-06 | 27 | 200 | 5 | CID000178028 | |
| Drug | AC1L18GM | 3.88e-06 | 13 | 200 | 4 | CID000000092 | |
| Drug | NSC 370147 | 4.15e-06 | 28 | 200 | 5 | CID000182762 | |
| Drug | NSC72302 | 4.15e-06 | 28 | 200 | 5 | CID000118078 | |
| Drug | L-quisqualic acid | ACHE TUBB2B TUBB2A TUBB4A TUBB4B TRIM49 TUBB PLCD4 GRIA4 TRIM49B | 4.57e-06 | 180 | 200 | 10 | CID000001209 |
| Drug | GaCl3 | 4.91e-06 | 50 | 200 | 6 | CID000026010 | |
| Drug | Z)-combretastatin A-4 | 4.91e-06 | 50 | 200 | 6 | CID000072686 | |
| Drug | oxibendazole | 4.98e-06 | 29 | 200 | 5 | CID000004622 | |
| Drug | isocarbophos | 5.40e-06 | 14 | 200 | 4 | ctd:C549713 | |
| Drug | AC1NBBHE | 5.93e-06 | 30 | 200 | 5 | CID004490620 | |
| Drug | eleutherobin | 5.93e-06 | 30 | 200 | 5 | CID006918335 | |
| Drug | azatoxin | 5.93e-06 | 30 | 200 | 5 | CID000125383 | |
| Drug | NSC617668 | 5.93e-06 | 30 | 200 | 5 | CID000357989 | |
| Drug | citostal | 5.93e-06 | 30 | 200 | 5 | CID000018991 | |
| Drug | thiocolchicine | 5.93e-06 | 30 | 200 | 5 | CID000017648 | |
| Drug | LEO275 | 6.17e-06 | 79 | 200 | 7 | CID000018140 | |
| Drug | bufuralol | 6.59e-06 | 5 | 200 | 3 | ctd:C010831 | |
| Drug | tropolone | 6.94e-06 | 53 | 200 | 6 | CID000010789 | |
| Drug | NSC609395 | 7.02e-06 | 31 | 200 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 7.02e-06 | 31 | 200 | 5 | CID000100524 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 7.02e-06 | 31 | 200 | 5 | CID000032851 | |
| Drug | tropone | 7.02e-06 | 31 | 200 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 7.02e-06 | 31 | 200 | 5 | CID000122777 | |
| Drug | NSC332598 | 7.02e-06 | 31 | 200 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 7.02e-06 | 31 | 200 | 5 | CID000023678 | |
| Drug | NSC 89199 | 7.75e-06 | 54 | 200 | 6 | CID000003268 | |
| Drug | S)-monastrol | 7.75e-06 | 54 | 200 | 6 | CID000794323 | |
| Drug | AC1L1G95 | 8.26e-06 | 32 | 200 | 5 | CID000003583 | |
| Drug | NSC153858 | 8.26e-06 | 32 | 200 | 5 | CID000547450 | |
| Drug | 2,5-hexanedione | 9.60e-06 | 56 | 200 | 6 | CID000008035 | |
| Drug | mebendazole | 9.67e-06 | 33 | 200 | 5 | CID000004030 | |
| Drug | CA4P | 9.67e-06 | 33 | 200 | 5 | CID000370232 | |
| Drug | taltobulin | 9.67e-06 | 33 | 200 | 5 | CID006918637 | |
| Drug | NSC376450 | 1.13e-05 | 34 | 200 | 5 | CID000005605 | |
| Drug | discodermolide | 1.30e-05 | 35 | 200 | 5 | CID000643668 | |
| Drug | Cyclodextrins | 1.31e-05 | 6 | 200 | 3 | ctd:D003505 | |
| Drug | mepirodipine | 1.31e-05 | 6 | 200 | 3 | ctd:C050699 | |
| Drug | AC1O5Y0F | 1.73e-05 | 37 | 200 | 5 | CID006442852 | |
| Drug | DTAF | 1.73e-05 | 37 | 200 | 5 | CID000123934 | |
| Drug | albendazole | 1.73e-05 | 37 | 200 | 5 | CID000002082 | |
| Drug | baccatin III | 1.73e-05 | 37 | 200 | 5 | CID000065366 | |
| Drug | benzimidazole | 1.82e-05 | 93 | 200 | 7 | CID000005798 | |
| Drug | gnoscopine | 1.97e-05 | 38 | 200 | 5 | CID000004544 | |
| Drug | laulimalide | 1.97e-05 | 38 | 200 | 5 | CID006918457 | |
| Drug | Dolastatin 10 | 2.25e-05 | 39 | 200 | 5 | CID000100208 | |
| Drug | indopan | 2.28e-05 | 7 | 200 | 3 | ctd:C015293 | |
| Drug | sulprofos | 2.28e-05 | 7 | 200 | 3 | CID000037125 | |
| Drug | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | 2.28e-05 | 7 | 200 | 3 | ctd:C547858 | |
| Drug | 16-O-demethylaconitine | 2.28e-05 | 7 | 200 | 3 | ctd:C486136 | |
| Drug | 5-fluorotryptamine | 2.28e-05 | 7 | 200 | 3 | ctd:C034536 | |
| Drug | norfluoxetine | 2.28e-05 | 7 | 200 | 3 | ctd:C036139 | |
| Drug | quinidine-N-oxide | 2.28e-05 | 7 | 200 | 3 | CID000050979 | |
| Drug | 12-hydroxyellipticine | 2.28e-05 | 7 | 200 | 3 | ctd:C517214 | |
| Drug | fenvalerate | 2.39e-05 | 97 | 200 | 7 | ctd:C017690 | |
| Drug | AC1L8GZ1 | 2.55e-05 | 40 | 200 | 5 | CID000381235 | |
| Drug | indanone | 2.88e-05 | 41 | 200 | 5 | CID000006735 | |
| Drug | lumicolchicine | 2.88e-05 | 41 | 200 | 5 | CID000072624 | |
| Drug | bromocolchicine | 3.08e-05 | 21 | 200 | 4 | CID000161518 | |
| Disease | ptosis (implicated_via_orthology) | 2.86e-09 | 10 | 194 | 5 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 2.86e-09 | 10 | 194 | 5 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 2.86e-09 | 10 | 194 | 5 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 2.86e-09 | 10 | 194 | 5 | DOID:0090132 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 8.90e-09 | 12 | 194 | 5 | DOID:0050997 (implicated_via_orthology) | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 2.77e-06 | 5 | 194 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 2.77e-06 | 5 | 194 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 2.77e-06 | 5 | 194 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 1.53e-05 | 8 | 194 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | Selective serotonin reuptake inhibitor response | 4.30e-05 | 2 | 194 | 2 | cv:CN221268 | |
| Disease | Trimipramine response | 4.30e-05 | 2 | 194 | 2 | cv:CN221259 | |
| Disease | Imipramine response | 4.30e-05 | 2 | 194 | 2 | cv:CN221257 | |
| Disease | Amitriptyline response | 4.30e-05 | 2 | 194 | 2 | cv:CN176769 | |
| Disease | Congenital anosmia | 4.30e-05 | 2 | 194 | 2 | C0393778 | |
| Disease | Doxepin response | 4.30e-05 | 2 | 194 | 2 | cv:CN077978 | |
| Disease | X-11308 measurement | 4.44e-05 | 11 | 194 | 3 | EFO_0800693 | |
| Disease | collagen disease (implicated_via_orthology) | 5.89e-05 | 12 | 194 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 7.62e-05 | 13 | 194 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MAN2C1 CYP2D6 MAOA ACHE PFKFB4 PDCD4 BCAR3 DNAH9 CNGA2 ARFGEF2 ELP1 ABCB6 LIPE PBRM1 TXNDC15 ARAP3 CST4 TENM1 CDA | 9.34e-05 | 1074 | 194 | 19 | C0006142 |
| Disease | Substance abuse problem | 1.22e-04 | 116 | 194 | 6 | C0740858 | |
| Disease | Bicuspid aortic valve | 1.28e-04 | 3 | 194 | 2 | HP_0001647 | |
| Disease | X-21258 measurement | 1.28e-04 | 3 | 194 | 2 | EFO_0800802 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.28e-04 | 3 | 194 | 2 | C1842563 | |
| Disease | glycine measurement, amino acid measurement | 2.56e-04 | 4 | 194 | 2 | EFO_0005134, EFO_0009767 | |
| Disease | Clozapine response | 2.56e-04 | 4 | 194 | 2 | cv:CN077971 | |
| Disease | Psychogenic coma | 4.24e-04 | 5 | 194 | 2 | C0860634 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 5.12e-04 | 24 | 194 | 3 | EFO_0003761, EFO_0005658 | |
| Disease | 3-methylglutaconate measurement | 6.34e-04 | 6 | 194 | 2 | EFO_0800047 | |
| Disease | Comatose | 6.34e-04 | 6 | 194 | 2 | C0009421 | |
| Disease | hexanoylglycine measurement | 8.84e-04 | 7 | 194 | 2 | EFO_0800233 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 8.84e-04 | 7 | 194 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | remission | 8.84e-04 | 7 | 194 | 2 | EFO_0009785 | |
| Disease | 1,5 anhydroglucitol measurement | 9.01e-04 | 29 | 194 | 3 | EFO_0008009 | |
| Disease | Drug habituation | 9.98e-04 | 115 | 194 | 5 | C0013170 | |
| Disease | Drug abuse | 9.98e-04 | 115 | 194 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 9.98e-04 | 115 | 194 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 9.98e-04 | 115 | 194 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 9.98e-04 | 115 | 194 | 5 | C0013222 | |
| Disease | Drug Dependence | 9.98e-04 | 115 | 194 | 5 | C1510472 | |
| Disease | Substance Dependence | 9.98e-04 | 115 | 194 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 9.98e-04 | 115 | 194 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 9.98e-04 | 115 | 194 | 5 | C0029231 | |
| Disease | response to antidepressant | 1.12e-03 | 176 | 194 | 6 | GO_0036276 | |
| Disease | mean platelet volume | FOXK2 PHF20 PCNX3 NFASC PFKFB4 LIN9 EFHC1 COCH VPS37D PCDHGB3 SH3KBP1 TUBB CPS1 VWA7 FAM13A DNM3 | 1.22e-03 | 1020 | 194 | 16 | EFO_0004584 |
| Disease | Tremor, Neonatal | 1.50e-03 | 9 | 194 | 2 | C0235843 | |
| Disease | Tremor, Perioral | 1.50e-03 | 9 | 194 | 2 | C0235078 | |
| Disease | Nerve Tremors | 1.50e-03 | 9 | 194 | 2 | C0235083 | |
| Disease | Tremor, Limb | 1.50e-03 | 9 | 194 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 1.50e-03 | 9 | 194 | 2 | C0235082 | |
| Disease | Senile Tremor | 1.50e-03 | 9 | 194 | 2 | C0149840 | |
| Disease | underweight body mass index status | 1.50e-03 | 9 | 194 | 2 | EFO_0005936 | |
| Disease | Pill Rolling Tremor | 1.50e-03 | 9 | 194 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 1.50e-03 | 9 | 194 | 2 | C0751565 | |
| Disease | Action Tremor | 1.50e-03 | 9 | 194 | 2 | C0234376 | |
| Disease | Passive Tremor | 1.50e-03 | 9 | 194 | 2 | C0234377 | |
| Disease | Static Tremor | 1.50e-03 | 9 | 194 | 2 | C0234378 | |
| Disease | Resting Tremor | 1.50e-03 | 9 | 194 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 1.50e-03 | 9 | 194 | 2 | C0234372 | |
| Disease | Fine Tremor | 1.50e-03 | 9 | 194 | 2 | C0234373 | |
| Disease | Coarse Tremor | 1.50e-03 | 9 | 194 | 2 | C0234374 | |
| Disease | Massive Tremor | 1.50e-03 | 9 | 194 | 2 | C0234375 | |
| Disease | Persistent Tremor | 1.50e-03 | 9 | 194 | 2 | C0234370 | |
| Disease | Continuous Tremor | 1.50e-03 | 9 | 194 | 2 | C0234371 | |
| Disease | Darkness Tremor | 1.50e-03 | 9 | 194 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 1.50e-03 | 9 | 194 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 1.50e-03 | 9 | 194 | 2 | C0040827 | |
| Disease | X-17653 measurement | 1.50e-03 | 9 | 194 | 2 | EFO_0800783 | |
| Disease | peak expiratory flow | 1.79e-03 | 498 | 194 | 10 | EFO_0009718 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.84e-03 | 132 | 194 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.87e-03 | 10 | 194 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Congenital disorder of glycosylation | 1.99e-03 | 38 | 194 | 3 | cv:C0282577 | |
| Disease | hepatocyte growth factor-like protein measurement | 1.99e-03 | 38 | 194 | 3 | EFO_0008154 | |
| Disease | glycine measurement | 2.16e-03 | 137 | 194 | 5 | EFO_0009767 | |
| Disease | Schizophrenia | CYP2D6 MAOA ACHE NFASC NRXN3 ALDH3B1 DNM1 QKI GRIA4 PBRM1 TENM4 PLA2G4B BECN1 FYN | 2.22e-03 | 883 | 194 | 14 | C0036341 |
| Disease | 3-methylglutarylcarnitine (2) measurement | 2.27e-03 | 11 | 194 | 2 | EFO_0800074 | |
| Disease | Tremor | 2.27e-03 | 11 | 194 | 2 | C0040822 | |
| Disease | Drug toxicity | 2.32e-03 | 84 | 194 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 2.32e-03 | 84 | 194 | 4 | C0041755 | |
| Disease | Colorectal Carcinoma | TUBB2A FAT1 PTPRS PZP QKI ABCB6 PEX5L ARAP3 PUS10 TENM1 DCHS1 TSKS | 2.48e-03 | 702 | 194 | 12 | C0009402 |
| Disease | Prenatal Exposure Delayed Effects | 2.72e-03 | 12 | 194 | 2 | C0033054 | |
| Disease | thymol sulfate measurement | 2.72e-03 | 12 | 194 | 2 | EFO_0021170 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.85e-03 | 43 | 194 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | interleukin 7 measurement | 3.24e-03 | 45 | 194 | 3 | EFO_0008189 | |
| Disease | hemolysis | 3.67e-03 | 47 | 194 | 3 | EFO_0009473 | |
| Disease | superior parietal cortex volume measurement | 4.27e-03 | 15 | 194 | 2 | EFO_0010330 | |
| Disease | X-17654 measurement | 4.27e-03 | 15 | 194 | 2 | EFO_0800784 | |
| Disease | platelet component distribution width | LIN9 DNM1 QKI MTCH2 VPS37D TUBB LAMA5 CPS1 VWA7 RBPMS2 DNM3 NUMB | 4.43e-03 | 755 | 194 | 12 | EFO_0007984 |
| Disease | Acute kidney injury | 4.50e-03 | 101 | 194 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 4.50e-03 | 101 | 194 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 4.50e-03 | 101 | 194 | 4 | C0022660 | |
| Disease | cochlin measurement | 4.86e-03 | 16 | 194 | 2 | EFO_0801481 | |
| Disease | Behcet's syndrome | 5.15e-03 | 53 | 194 | 3 | EFO_0003780 | |
| Disease | handedness | 5.34e-03 | 106 | 194 | 4 | EFO_0009902 | |
| Disease | response to radiation, Urinary retention | 5.48e-03 | 17 | 194 | 2 | GO_0009314, HP_0000016 | |
| Disease | cystatin-D measurement | 5.48e-03 | 17 | 194 | 2 | EFO_0008103 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVPVNSLRFLFEGQR | 56 | G2XKQ0 | |
| SRAEFLAGVRVGVPQ | 386 | P22303 | |
| FVNAQFPRFSPVLGR | 486 | Q9NRG9 | |
| VSVFGITRGQFAALP | 791 | O75366 | |
| LQALPEGSVLRRGFQ | 1151 | Q9P2K9 | |
| FVQVPGFPRRGRLAV | 371 | P78357 | |
| FPFSFELILAGGRIQ | 751 | Q8WWN8 | |
| VDGLPLQRYQGLRFV | 356 | Q6L9W6 | |
| GNRRPISQQSGAIIF | 236 | O75815 | |
| LNIFPDGGIARLRVF | 166 | Q8N6M5 | |
| NFIQIRRVFPTNFPG | 126 | O60242 | |
| RPAEFRAAQLQGLGR | 21 | P43353 | |
| LRTFLEGFRLPGEAQ | 726 | Q9Y6D5 | |
| PQERNIFNRIFGGFL | 301 | Q9Y305 | |
| GPLRFQKGRIEFENV | 581 | Q9NP58 | |
| LQLLPNRTGSRGFVD | 2601 | Q96M86 | |
| ELGPSLRRNVGFQVR | 506 | Q7L2E3 | |
| VLVVGQRLGTIRFFG | 491 | Q8N3C7 | |
| SPRVRVNFFGLLTFQ | 136 | Q96Q80 | |
| LGFEPRGTAIGQRLV | 221 | Q96F81 | |
| RGANFLTQILLRPGA | 166 | O60762 | |
| TIFQRGFDLVLGEQP | 521 | O14525 | |
| FFRSLQGRVFPTQLQ | 1291 | O60312 | |
| AREALAIVFFGRQPQ | 121 | Q16853 | |
| LGAFSGPRIFDVRFQ | 341 | Q16853 | |
| GPRIFDVRFQGERLV | 346 | Q16853 | |
| RNIFGRQVCQLPGLF | 41 | Q9Y6C9 | |
| ARQPVGFVIFDSRAG | 66 | Q6ZRY4 | |
| RQGIPFFAQVLLVDG | 356 | P20742 | |
| LRGIFEPFGRIESIQ | 266 | Q14498 | |
| FHRSIRNFVIQGGDP | 321 | Q13356 | |
| GNFLIIFTIRSDPGL | 41 | A0A096LPK9 | |
| LANRQPDFISFGLVG | 3716 | P98160 | |
| FNFVGRILGPRGLTA | 96 | Q96PU8 | |
| GRTISVQFNQLFLRP | 396 | Q75QN2 | |
| PVFAGFEGRRTNEIN | 336 | P0C860 | |
| TFQIDPQNGEVRLRG | 291 | Q9Y5F3 | |
| VGNFAARLLVRLFPE | 736 | Q5T5X7 | |
| RGDPVLSFFIQGNRI | 656 | O95170 | |
| RVIRQPVGRIFFAGT | 421 | P21397 | |
| AGDLLQQFRTVRSFP | 296 | Q14517 | |
| QQGRRDLRFQPVSIG | 4586 | Q99102 | |
| FQLRIEARDGGQPAL | 1821 | Q96JQ0 | |
| LFNVVLEAREPGSGR | 526 | Q86U86 | |
| FGLSLGPRTRVQAEN | 11 | P59901 | |
| GGFPVEFLIQVTRLS | 336 | Q5TKA1 | |
| RALNVPRVGLVFTDG | 486 | O95460 | |
| LRRLISPNLGVVFFN | 326 | Q66K74 | |
| IAPGRLVGLNVFSQF | 2536 | Q5T1H1 | |
| AGQVFFVPGRLTLSE | 246 | Q9GZV7 | |
| NRDGRVTLGPTQVFL | 2706 | Q8IWI9 | |
| VFVDGVFQRRGAPPL | 121 | Q01167 | |
| PTVLGQVFRLLDSGF | 26 | Q5JYT7 | |
| SVLENFVGRDFLPRG | 46 | Q05193 | |
| TQFPERGRFLQLQAL | 3641 | Q8NDA2 | |
| ATARAFLVVRGEPQG | 4381 | Q8NDA2 | |
| QFGTINNFRLGRLPS | 281 | Q14457 | |
| VFDRGNNRVGLAPAV | 381 | P14091 | |
| SVLENFVGRDFLPRG | 46 | Q9UQ16 | |
| GESQFVLQLRPSLRG | 126 | P48058 | |
| VVSGGFPIIRDQIFR | 256 | Q9UK99 | |
| GNGLVTFQLRGLEFR | 1436 | A6NKB5 | |
| GNGLVTFQLRGLEFR | 1391 | Q9H6A9 | |
| RAPQLVGQFIARAVG | 256 | Q53EL6 | |
| QGPQEGLFAFVVRLE | 416 | A0A0J9YXQ4 | |
| GALGNRPFRAFVVTD | 16 | P51805 | |
| PRFERFGLGVLESSN | 906 | Q8IVT5 | |
| GNFLIIFTIRSDPGL | 41 | Q8N0Y3 | |
| PRRGQIIDFQGLLTD | 181 | Q8IYT4 | |
| DNRLPLENGRFIAGT | 201 | A6NDG6 | |
| EIQPGFIRSRYNLGI | 536 | Q8IYB4 | |
| PLAGSLRRDVVEGNF | 201 | Q9H1Q7 | |
| IGVPTREFNVGQYRR | 66 | Q16877 | |
| ARFGLRNIIADPVTF | 861 | Q9Y4C0 | |
| FSRVGADFRGQLAPV | 356 | Q96MW5 | |
| ADFRGQLAPVFQRVA | 361 | Q96MW5 | |
| EAIPERGNGFRLLSA | 21 | Q6AI08 | |
| GFPRFLDTGVVQSDR | 1346 | Q7Z7M0 | |
| NFLRNGELLLPEGFR | 91 | Q8WVF5 | |
| LFRTLEFRDIQGPGN | 6 | O95163 | |
| TFGLTDRPRLFQQFG | 201 | Q13087 | |
| PQGEGRLEVEFRLQS | 116 | P0C869 | |
| FVQRLLGPQRVFDLQ | 3266 | O15230 | |
| FGVGDLPTRNLRVIA | 56 | Q9Y5G1 | |
| SVLENFVGRDFLPRG | 46 | P50570 | |
| SALQPRFIQLFQDGR | 131 | O94988 | |
| VEQELRLVGPRGFSQ | 1761 | Q7Z442 | |
| QRLFGFQPLASREVD | 26 | Q96IR7 | |
| GLGAFTPVVRQRTLQ | 601 | Q13332 | |
| LQLAAVGARIPFRVG | 611 | Q9Y5I0 | |
| QSAAVGARIPFRVGL | 611 | Q9Y5I2 | |
| QASRFDIPLGLQGTR | 1101 | O94913 | |
| LSRNPRGFFLFVEGG | 321 | P05187 | |
| RQQASFPGDRLRGVV | 881 | O94856 | |
| NIAFFGGDPRRITVF | 271 | Q9NZ94 | |
| RAGEPLGVTFRVENN | 136 | Q9NZW5 | |
| DVRTLGNGRPFAIEL | 346 | Q3MIT2 | |
| GFQGNPTTLEARLRL | 221 | Q9H974 | |
| FRDLQLGREQLVPGS | 351 | P58658 | |
| GILIGIQQSFRPRFL | 1361 | P31327 | |
| FLQGLRDDGFQPTIL | 51 | Q8IV32 | |
| ALTDFPQRGLFVVRL | 126 | Q8WWV6 | |
| FFRIRAVNEAGVGEP | 871 | Q8N9C0 | |
| EPVQQLGAVGREAFF | 721 | Q8N6C5 | |
| ANFTLQDRGAGPRVE | 131 | Q6UX52 | |
| FCLETLPQFRVDGRG | 191 | P17658 | |
| PLAERANRGFGIVFS | 101 | P33261 | |
| DGRPVNNFEFFRPLV | 256 | Q8WUS8 | |
| FALGFPLNVLAIRGA | 16 | O14842 | |
| FGTPVINLGTRQIGR | 311 | Q9Y223 | |
| RLFVVRGQPADVFPR | 91 | Q49AN0 | |
| QRLEFRLVPGQRFGL | 456 | Q9Y6A2 | |
| RLVPGQRFGLQEQAT | 461 | Q9Y6A2 | |
| RVAVFRLLGFEPFSQ | 331 | Q92847 | |
| ITQILGFGPRSQGVF | 106 | P10635 | |
| FLRGLQVNGSRPGTF | 181 | Q10981 | |
| RQLLSFGNPRGTFLI | 161 | P06241 | |
| VRGFVAGATNILFRQ | 426 | Q8NBF6 | |
| QQPIFVFLLSTRAGG | 411 | Q86WJ1 | |
| QANRLPGIFDDVRGS | 281 | Q7Z5Y6 | |
| AFLGQVLVRRLPNGT | 101 | P29372 | |
| TALLAIRRGNPGSFQ | 151 | Q9H222 | |
| RIQEFACRGQFVPVG | 316 | Q9NTJ4 | |
| GIAAIREQVRFNGFG | 176 | O43462 | |
| RRPTVGIGGDRLQFN | 41 | Q5JVL4 | |
| ERGILVASNPRGLFV | 276 | Q00978 | |
| ELRQRIQGPFSNFGR | 616 | Q9NYC9 | |
| PLAERANRGFGIVFS | 101 | P11712 | |
| FSGCRQIGSLRPFVQ | 1571 | Q9Y4K1 | |
| LPVIGQNLRFQRLFT | 991 | P54198 | |
| VGSFEILPGRQFRVV | 856 | Q9BYK8 | |
| IAFLIDGSFNIGQRR | 166 | O43405 | |
| RPLQVLRAREQTFGG | 66 | P01036 | |
| LSRAPSRGGVNFLNV | 6 | Q9P1Z2 | |
| RFTARPLVQTIFEGG | 326 | Q99661 | |
| GFLPISLIAGFQRVQ | 246 | Q659C4 | |
| RLLVTNRPGVLFFEG | 431 | Q05469 | |
| PNRRGISFEVGAQLE | 6 | Q9BVI0 | |
| VFGRIGAGFVLNREP | 341 | O15403 | |
| APIEQLARQGSFRGF | 266 | P49757 | |
| VGFPAQLYQERLQRG | 76 | Q9P2B2 | |
| FQGNQFLRFDPVRGE | 201 | P02790 | |
| VRAGELDQALGRPFT | 366 | Q9BST9 | |
| LFDISGRAPLRQFEG | 106 | Q8TED0 | |
| SAGPITGLRDRLNQF | 271 | P0CI25 | |
| DGGTRVLVQLSPQFR | 1126 | A2VEC9 | |
| VLVQLSPQFRGRVAG | 1131 | A2VEC9 | |
| PLEQGFTIVFHGRRS | 86 | Q9BRC7 | |
| GEVRGRTGIFPLNFV | 611 | Q5HYK7 | |
| GRLQDREGIFPAVFV | 701 | Q5HYK7 | |
| ILIAGQFRGRPFISV | 316 | O75019 | |
| DGIQDPRNFGAVLRS | 151 | Q6IN84 | |
| APVNGSVFIALLRRF | 76 | Q9H6Y7 | |
| PRFLRSFFLGQGLSA | 141 | Q9HAB3 | |
| INGRRGLFPDNFVRE | 41 | Q96B97 | |
| LNGRRGVFPDNFVKL | 311 | Q96B97 | |
| QFLPFLQRAGRSEAV | 516 | Q7KZF4 | |
| TRGVAPRVNFEGALF | 6 | Q86YJ6 | |
| VRSGPFGQIFRPDNF | 76 | Q13885 | |
| RQTGPLIGRQIFRFS | 2016 | Q9UKZ4 | |
| PGAQFLIRTGSVGRN | 76 | Q9UBE0 | |
| IDRLGLFSGRFQAPS | 996 | Q6P9B9 | |
| ADGIPFFRSANGVIL | 186 | Q86TN4 | |
| FFRGPTVSNIRLAGL | 166 | Q9H7B2 | |
| PFLGREALEQQRAAG | 806 | Q9UL12 | |
| RAILQRVQAAAFGPG | 86 | Q9BT30 | |
| NTAFFGDVVLRFPRI | 111 | Q9H6E4 | |
| DQLFRIFRALGTPNN | 211 | P06493 | |
| FPVGAALLTQEGRIF | 36 | P32320 | |
| GGVVASLRFPRVAQQ | 1166 | O75339 | |
| VDAPQQGRSGFRRIV | 56 | Q16280 | |
| FVLRSINPFGNSRLV | 361 | P51790 | |
| RFGGDQPVYINIIRD | 176 | Q9Y2C2 | |
| FNPETRRLSIGLDNG | 76 | Q96P53 | |
| NRNRIASFPGFLFVL | 141 | Q96BF3 | |
| QFPRALGLFTVLDGL | 361 | O15375 | |
| AQGQPVAGTERSRFL | 1136 | Q9UJ98 | |
| RQEGLGVFFRGVTIN | 251 | Q8N413 | |
| VANLFRQLGFAPGDV | 116 | Q6PCB7 | |
| RQLGFAPGDVVAIFL | 121 | Q6PCB7 | |
| TFRPLVDSVLQGFNG | 76 | O15066 | |
| VRSGPFGQIFRPDNF | 76 | P04350 | |
| DPIGRDFIGQRTLAF | 841 | O75038 | |
| RGFRIRAVGDVFPVQ | 96 | Q6ZVD7 | |
| RSVAQDPVGGRFVVL | 111 | A6NE52 | |
| VRSGPFGQIFRPDNF | 76 | Q9BVA1 | |
| VRSGPFGQIFRPDNF | 76 | P68371 | |
| SAGPITGLRDRLNQF | 271 | P0CI26 | |
| FQQQRFDRGVGAEPL | 876 | Q9H0D6 | |
| RFGTVAVPNILLFQG | 256 | Q96J42 | |
| RLGGPQLRVFRTNFF | 11 | Q16540 | |
| VRSGPFGQIFRPDNF | 76 | P07437 | |
| VPAFQVIFTLGGTRA | 6 | A0A0B4J262 | |
| NVRENFSVPVGLRGT | 1111 | Q8IZH2 | |
| PFLSGAEGQLERVAR | 886 | Q7Z410 | |
| GPLIDRQIFRFTEEG | 2061 | Q6N022 | |
| LVGFATEPQFLGRAA | 261 | Q9H1K6 | |
| LGAGQFSFQRPLLVL | 246 | Q8WVM8 | |
| LEEFGRQFQNSRRGP | 421 | Q9UJT2 | |
| EQSLEAFLPAFQRGR | 141 | Q86XT2 | |
| RNRSFQPGLDNIIFV | 46 | O43548 | |
| VGFRAIAFLQQPRSL | 421 | P22102 | |
| FQAIKGFRNAPVGIR | 31 | O60830 | |
| RPSENLGQVLFGERI | 91 | Q99805 | |
| GQVLQAGELVFRPRD | 766 | Q13105 | |
| RVNDLFRIIPGIGNF | 511 | Q9NWZ5 | |
| SAGPITGLRDRLNQF | 271 | A6NDI0 | |
| VRRDSGLQPFGSLFL | 81 | Q6AWC8 | |
| RPFSLELIGQDAAGR | 696 | Q9Y334 | |
| GRPRDNQAIEFLFQL | 466 | Q96J92 | |
| ESNPLGQEVFRLRFR | 41 | Q15776 | |
| DGPFLDGINVTIRRN | 716 | Q15386 | |
| LVGAFPIFVRNAILG | 381 | Q9BWF2 | |
| RQINFRLFEDGTLGI | 456 | P23378 | |
| FNPSGVIEGARIEQF | 221 | Q6PIF6 |